| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |